Startup InPress Reports First Clinical Data For Postpartum Hemorrhage Device
This article was originally published in The Gray Sheet
Executive Summary
Data from 10 patients supports quick action to stop hemorrhages, the leading cause of perinatal maternal death. InPress Technologies hopes to launch an FDA trial later this year.
You may also be interested in...
News In Brief
Boston Scientific acquires C.R. Bard’s electrophysiology business. European Council issues a progress report on device reforms. More news in brief.
What’s Next? Five Things To Look Out For In April
Generics Bulletin previews the biggest events and changes for industry in the coming month.
Keeping Track: More Rx-To-OTC Switches On Deck After US FDA’s OTC Narcan Approval; Iovance Looks To Bring Cell Therapy To Melanoma
The latest drug development news and highlights form the Pink Sheet’s US FDA Performance Tracker.